Dr. Marshall talks with Today Show about why colon cancer is on the rise in young patients
The 2018 Ruesch Center Annual Report
Highlights of the Ruesch Center from the past year include our latest in research and clinical trials, partnerships regionally and internationally, and our education, advocacy and outreach efforts.
Relentlessly fighting a smarter war against GI cancer by partnering with patients based on their unique needs, the Ruesch Center is committed to providing you with the highest standard of care and individualized cures.
Search our current GI clinical trials offered through the MedStar Georgetown Cancer Institute
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
-
Second-leading cancer killer on the rise in young adults
-
Genomic and Transcriptomic Profiling Finds Potential Predictors and Therapeutic Targets in Pancreatic Cancer
-
When you have stage 4 cancer, the shutdown is about more than a missed paycheck
-
Looking for Zebras in Metastatic Colorectal Cancer
-
Immunotherapy Could Have Role in Frontline HCC
-
Ruesch Center and OncLive Recognize Former VP Biden at the Luminary Awards
-
Discussing Drug Development & Complexity in Clinical Trials at the 9th Annual Ruesch Symposium
-
OncLive® and The Ruesch Center for the Cure of Gastrointestinal Cancers Honored the 2018 Honorees of the Second Annual Luminary Awards in GI Cancers
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver our quarterly newsletter, monthly updates and other announcements to your Inbox with information on upcoming special events, current clinical trials and cutting edge research and trends in the GI cancer field.